why choose us

First received: December 08, 2022

Clinical Trial: Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Malignant Solid Neoplasm

Study Type: INTERVENTIONAL


Official Title: A Phase I Study of Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) in Patients With Advanced Solid Tumors

Brief Summary: This phase I trial tests the safety, side effects, and best dose of a new drug called nab-paclitaxel/STI-3031 complex (AP160-complex) in treating patients with solid tumors that may have spread from where they first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that have spread from where they first started (primary site) to other distant parts of the body (metastatic).AP160-complex is a combination of the chemotherapy drug nab-paclitaxel, and the immunotherapy drug…

Read more